NeOnc to Present Data at SNO 2026
NeOnc Technologies announced it will present data on its NEO100 and NEO212 clinical programs at the Society for Neuro-Oncology's 2026 Annual Meeting, highlighting progress in CNS cancer therapies. The data event adds visibility to the clinical development pipeline and therapeutic potential of the company's portfolio.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed